Additionally, according to prior studies, the oncofetal protein IGF2BP3 has been reported as a predominant cancer-specific marker differentiating benign from malignant lesions of pancreas and uterine cervix (57, 58), highly indicating that increased IGF2BP3 expression was associated with unfavorable prognosis among tumor tissues. This evidence concerns the gene IGF2BP3 and neoplasm.